Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ocular Oncology
•
Ophthalmology
How can advanced imaging tools and AI help distinguish small benign melanocytic lesions from early melanoma?
Related Questions
How do you determine the role of adjunctive therapies for a patient with conjunctival squamous cell carcinoma (SCC) that has recurred after initial surgical excision?
What is the appropriate interval before safely performing cataract surgery after plaque radiation therapy for iris melanoma?
How do you approach the management of a patient with a small, indeterminate choroidal mass with no obvious primary malignancy?
When should amblyopia treatment be initiated in patients being treated for retinoblastoma?
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
How would you advise a younger patient with residual/recurrent optic nerve meningioma, proceeding with radiotherapy, about the risks of malignant transformation or induction of other brain malignancies because of radiation?
How do you decide on treatment modality for ocular surface squamous neoplasia?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
How do you approach the management of indeterminate orbital lesions in asymptomatic patients with inconclusive imaging findings?
